MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 144 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is 2.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,000 | -75.0% | 1,600 | 0.0% | 0.00% | – |
| Q1 2017 | $4,000 | -33.3% | 1,600 | 0.0% | 0.00% | – |
| Q4 2016 | $6,000 | -57.1% | 1,600 | -30.4% | 0.00% | – |
| Q3 2016 | $14,000 | +16.7% | 2,300 | 0.0% | 0.00% | – |
| Q2 2016 | $12,000 | -36.8% | 2,300 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $19,000 | +18.8% | 2,300 | +12.2% | 0.00% | 0.0% |
| Q4 2015 | $16,000 | +6.7% | 2,050 | +10.8% | 0.00% | 0.0% |
| Q3 2015 | $15,000 | -31.8% | 1,850 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $22,000 | +4.8% | 1,850 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $21,000 | +23.5% | 1,850 | +19.4% | 0.00% | 0.0% |
| Q4 2014 | $17,000 | +1600.0% | 1,550 | +675.0% | 0.00% | – |
| Q3 2014 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2014 | $1,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,442,159 | $15,508,000 | 3.96% |
| Consonance Capital Management LP | 5,950,225 | $37,784,000 | 3.64% |
| Lagoda Investment Management, L.P. | 1,870,777 | $11,879,000 | 3.57% |
| ALTFEST L J & CO INC | 39,490 | $1,508,000 | 1.00% |
| GARRISON BRADFORD & ASSOCIATES INC | 82,700 | $525,000 | 0.49% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 8,894,008 | $56,477,000 | 0.46% |
| Cannell & Co. | 1,611,678 | $10,234,000 | 0.37% |
| Portolan Capital Management | 412,189 | $2,617,000 | 0.36% |
| Virtus ETF Advisers LLC | 100,090 | $636,000 | 0.31% |
| INDUS CAPITAL PARTNERS, LLC | 500,000 | $3,175,000 | 0.30% |